Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2012
View Archived Issues
Novel antithrombotic agents presented by Bristol-Myers Squibb
Read More
New tamsulosin prodrugs prepared by Synthon
Read More
Affectis Pharmaceuticals presents novel P2X7 receptor antagonists
Read More
Novel monoclonal antibodies patented by IRM and Novartis
Read More
Mepolizumab reduces exacerbation rates in asthma patients
Read More
Third patient successfully treated with Pluristem's PLX cells
Read More
Phase I/II ublituximab trial begins in B-cell non-Hodgkin's lymphoma
Read More
Researchers at Zyngenia disclose novel fusion proteins
Read More
Light study of Contrave experiences accelerated enrollment
Read More
Oncothyreon expands phase II trial of PX-866
Read More
Novel S1P4 receptor antagonists synthesized by Biogen Idec
Read More
ImmunoCellular Therapeutics completes enrollment in ICT-107 trial
Read More
BT-2111 shows promise in animal models of breast cancer
Read More
Adynxx's AYX-1 set to move to phase II
Read More
Targacept to develop TC-5214 in overactive bladder
Read More
Phase II results demonstrate efficacy of QMF-149 in patients with persistent asthma
Read More
ALV-003 receives FDA fast track designation for celiac disease
Read More
New lysophospholipid S1P1 receptor agonists presented at ACS meeting
Read More
Rienso receives Swiss marketing authorization
Read More
NPS Pharmaceuticals updates plans for Natpara BLA
Read More
Baxter begins phase I monoclonal antibody trial in patients with solid tumors
Read More
Acadia Pharmaceuticals completes enrollment in phase III pimavanserin trial
Read More
Study evaluates dose-response of umeclidinium in COPD
Read More
Meda to buy Jazz Pharmaceuticals' women's health business
Read More
FDA extends PDUFA date for Ravicti NDA
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe